This is the authors' abstract. We don't add key points for this paper.
Novel HIV vmiR88 and vmiR99 are present in the systemic circulation of HIV+ persons and could exhibit biological function (independent of gene silencing) as ligands for TLR8 signaling that promote macrophage TNFα release, and may contribute to chronic immune activation. Targeting novel HIV-derived miRNAs may represent a therapeutic strategy to limit chronic immune activation and AIDS progression.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bernard et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: